Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:O95477 (
membrane-bound
)
29,236
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We report the cloning and characterization of a novel
membrane-bound
, calcium-independent PLA2, named
cPLA2-gamma
. The sequence encodes a 541-amino acid protein containing a domain with significant homology to the catalytic domain of the 85-kDa cPLA2 (cPLA2-alpha).
cPLA2-gamma
does not contain the regulatory calcium-dependent lipid binding (CaLB) domain found in cPLA2-alpha. However,
cPLA2-gamma
does contain two consensus motifs for lipid modification, a prenylation motif (-CCLA) at the C terminus and a myristoylation site at the N terminus. We present evidence that the isoprenoid precursor [3H]mevalonolactone is incorporated into the prenylation motif of
cPLA2-gamma
. Interestingly,
cPLA2-gamma
demonstrates a preference for arachidonic acid at the sn-2 position of phosphatidylcholine as compared with palmitic acid.
cPLA2-gamma
encodes a 3-kilobase message, which is highly expressed in heart and skeletal muscle, suggesting a specific role in these tissues. Identification of
cPLA2-gamma
reveals a newly defined family of phospholipases A2 with homology to cPLA2-alpha.
...
PMID:A novel calcium-independent phospholipase A2, cPLA2-gamma, that is prenylated and contains homology to cPLA2. 970 32